CC
Casdin Capital Portfolio holdings
AUM
$1.1B
1-Year Return
24.98%
This Quarter Return
-22.35%
1 Year Return
+24.98%
3 Year Return
+152.8%
5 Year Return
+110.01%
10 Year Return
–
AUM
$84.5M
AUM Growth
-$22.9M
(-21%)
Cap. Flow
+$6.47M
Cap. Flow
% of AUM
7.66%
Top 10 Holdings %
Top 10 Hldgs %
68.91%
Holding
33
New
5
Increased
12
Reduced
6
Closed
7
Top Buys
| 1 |
FMI
Foundation Medicine, Inc.
FMI
|
$4M |
| 2 |
Editas Medicine
EDIT
|
$2.95M |
| 3 |
EPZM
Epizyme, Inc
EPZM
|
$2.58M |
| 4 |
Agios Pharmaceuticals
AGIO
|
$2.09M |
| 5 |
KITE
Kite Pharma, Inc.
KITE
|
$2.07M |
Top Sells
| 1 |
Illumina
ILMN
|
$5.76M |
| 2 |
GHDX
Genomic Health, Inc.
GHDX
|
$2.72M |
| 3 |
GNMK
GenMark Diagnostics, Inc
GNMK
|
$2.41M |
| 4 |
NVTA
Invitae Corporation
NVTA
|
$2.05M |
| 5 |
BPMC
Blueprint Medicines
BPMC
|
$1.65M |
Sector Composition
| 1 | Healthcare | 87.92% |
| 2 | Industrials | 0.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Atara Biotherapeutics
ATRA
$85.5M
| – | – |
-1,000
| Closed | -$660K |
|
27
Cardiff Oncology
CRDF
$145M
| – | – |
-972
| Closed | -$378K |
|
|
28
Illumina
ILMN
$15.4B
| – | – |
-30,840
| Closed | -$5.76M |
|
29
OraSure Technologies
OSUR
$232M
| – | – |
-170,000
| Closed | -$1.1M |
|
30
SPDR S&P Biotech ETF
XBI
$5.32B
| – | – |
0
| – | – |
|
|
NVTA
31
DELISTED
Invitae Corporation
NVTA
| – | – |
-250,000
| Closed | -$2.05M |
|
|
GNMK
32
DELISTED
GenMark Diagnostics, Inc
GNMK
| – | – |
-310,000
| Closed | -$2.41M |
|
|
JUNO
33
DELISTED
Juno Therapeutics, Inc.
JUNO
| – | – |
-17,500
| Closed | -$769K |
|